福建省药品监督管理局关于福州基石医药科技有限公司等5家药品生产企业2025年依职责GMP符合性检查结果的通告
Xin Lang Cai Jing·2026-01-22 06:52

Group 1 - The announcement details the GMP compliance inspection results for five pharmaceutical manufacturing companies in Fujian Province for the year 2025 [2] - The companies inspected include Fuzhou Jishi Pharmaceutical Technology Co., Ltd., Guangdong Xieai Pharmaceutical Co., Ltd. Fuzhou Branch, Fuzhou Atom High-Tech Co., Ltd., Fujian Tianquan Pharmaceutical Co., Ltd., and Fujian Huboliao Pharmaceutical Co., Ltd. [2] - All five companies received a "compliant" rating following their respective inspections, indicating adherence to Good Manufacturing Practices [2] Group 2 - The inspections were conducted by the Fujian Provincial Drug Supervision Administration in accordance with the Drug Administration Law and the Drug Production Supervision and Administration Measures [2] - The inspection results cover various production lines, including small volume injectables, radioactive drugs, raw materials, and solid dosage forms [2] - The inspection dates for the companies ranged from September to November 2025, with specific timelines provided for each company's inspection [2]